Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Heart (British Cardiac Society)|October 6, 2007
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimenP Lindgren, M Buxton, T Kahan, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|June 28, 2002
Influence of age and cardiovascular factors on regional pulsed wave Doppler myocardial imaging indicesM Edner, C Jarnert, R Müller-Brunotte, et al.
Journal of Hypertension|October 11, 2001
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patientsL Kurland, H Melhus, J Karlsson, et al.
Blood Pressure|March 31, 2025
Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in SwedenT Kahan, M L Johansen, A M Ryschon, et al.
Blood Pressure|June 30, 2004
A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA)H Brändström, F Stiger, T Kahan, et al.
International Journal of Clinical Practice|May 27, 2010
The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes TrialP Lindgren, J Eriksson, M Buxton, et al.
Clinical Cardiology|July 9, 2004
Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertensionJ Karlsson, L Lind, P Hallberg, et al.
Journal of Hypertension|June 14, 2001
Regression of left ventricular hypertrophy in human hypertension with irbesartanK Malmqvist, T Kahan, M Edner, et al.
Clinical Cardiology|June 11, 2004
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)P Hallberg, J Karlsson, L Lind, et al.
Journal of Internal Medicine|July 9, 2020
Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarctionR Edfors, L Lindhagen, J Spaak, et al.
Pageof 10